Cargando…

A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson’s disease

Biomarkers play important roles in the diagnosis and differential diagnosis of Parkinson’s disease (PD). Thus, we carried out a systematic review and meta-analysis evaluating the diagnostic utility of cerebrospinal fluid (CSF) biomarkers to distinguish PD from atypical parkinsonian syndromes (APSs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Chunchen, Cong, Shengri, Tan, Xiaoping, Ma, Shuang, Liu, Yang, Wang, Hailong, Cong, Shuyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709054/ https://www.ncbi.nlm.nih.gov/pubmed/36446820 http://dx.doi.org/10.1038/s41531-022-00431-7

Ejemplares similares

Author Correction: A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson’s disease
por: Xiang, Chunchen, et al.
Publicado: (2023)

Bioinformatic gene analysis for potential therapeutic targets of Huntington’s disease in pre-symptomatic and symptomatic stage
por: Xiang, Chunchen, et al.
Publicado: (2020)

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach
por: van Dijk, Karin D., et al.
Publicado: (2010)

Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies
por: Xiang, Chunchen, et al.
Publicado: (2018)

The Diagnostic and Differential Diagnosis Utility of Cerebrospinal Fluid α-Synuclein Levels in Parkinson's Disease: A Meta-Analysis
por: Zhou, Bo, et al.
Publicado: (2015)

What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?
por: Kim, Dana, et al.
Publicado: (2014)

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
por: Hall, Sara, et al.
Publicado: (2016)

Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease
por: Zimmermann, Milan, et al.
Publicado: (2022)

Cerebrospinal Fluid Biomarkers in Parkinson’s Disease: A Critical Overview of the Literature and Meta-Analyses
por: Katayama, Takayuki, et al.
Publicado: (2020)

Cerebrospinal Fluid Biomarkers in Multiple System Atrophy Relative to Parkinson's Disease: A Meta-Analysis
por: Xie, Dan, et al.
Publicado: (2021)

Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
por: Irwin, David J., et al.
Publicado: (2020)

Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
por: Hatcher-Martin, J. M., et al.
Publicado: (2021)

Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s disease
por: Karayel, Ozge, et al.
Publicado: (2022)

Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases
por: Schmitz, Matthias, et al.
Publicado: (2022)

MicroRNAs Dysregulation and Metabolism in Multiple System Atrophy
por: Xiang, Chunchen, et al.
Publicado: (2019)

Clinical utility of cerebrospinal fluid biomarkers measured by LUMIPULSE(®) system
por: Nojima, Hisashi, et al.
Publicado: (2022)

Metallomic Biomarkers in Cerebrospinal fluid and Serum in patients with Parkinson’s disease in Indian population
por: Sanyal, Jaya, et al.
Publicado: (2016)

MRI-visible perivascular spaces are associated with cerebrospinal fluid biomarkers in Parkinson’s disease
por: Fang, Yi, et al.
Publicado: (2020)

MicroRNAs in Huntington’s Disease: Diagnostic Biomarkers or Therapeutic Agents?
por: Dong, Xiaoyu, et al.
Publicado: (2021)

Increased Noradrenaline as an Additional Cerebrospinal Fluid Biomarker in PSP-Like Parkinsonism
por: Cerroni, Rocco, et al.
Publicado: (2020)

Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach
por: Marques, Tainá M., et al.
Publicado: (2021)

Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia
por: Forlenza, Orestes V., et al.
Publicado: (2015)

Metabolomic investigations in cerebrospinal fluid of Parkinson's disease
por: Willkommen, Desiree, et al.
Publicado: (2018)

MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy
por: Marques, Tainá M., et al.
Publicado: (2016)

Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson’s disease diagnosis
por: T. dos Santos, Marcia Cristina, et al.
Publicado: (2018)

Cerebrospinal Fluid Biomarkers for Kii Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex
por: Nakayama, Yui, et al.
Publicado: (2013)

A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profiles
por: Lehmann, Sylvain, et al.
Publicado: (2014)

Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer’s Disease
por: Niemantsverdriet, Ellis, et al.
Publicado: (2016)

Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
por: Jansen, Iris E., et al.
Publicado: (2022)

Cerebrospinal Fluid MicroRNA Signatures as Diagnostic Biomarkers in Brain Tumors
por: Kopkova, Alena, et al.
Publicado: (2019)

Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
por: Konen, Franz Felix, et al.
Publicado: (2022)

Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid
por: Barbariga, Marco, et al.
Publicado: (2015)

Profiling Inflammatory Extracellular Vesicles in Plasma and Cerebrospinal Fluid: An Optimized Diagnostic Model for Parkinson’s Disease
por: Vacchi, Elena, et al.
Publicado: (2021)

Harnessing Cerebrospinal Fluid Biomarkers in Clinical Trials for Treating Alzheimer's and Parkinson's Diseases: Potential and Challenges
por: Kim, Dana, et al.
Publicado: (2016)

Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson’s disease: protocol for a systematic review and individual participant data meta-analysis
por: Eusebi, Paolo, et al.
Publicado: (2017)

Motor Progression in Early-Stage Parkinson's Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers
por: Ma, Ling-Yan, et al.
Publicado: (2021)

Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease
por: Jiménez-Jiménez, Félix J., et al.
Publicado: (2014)

Proteome analysis of human cerebrospinal fluid as a diagnostic biomarker in patients with meningioma
por: Kim, Jae Ho, et al.
Publicado: (2012)

Cerebrospinal fluid lactate level as a diagnostic biomarker for bacterial meningitis in children
por: Mekitarian Filho, Eduardo, et al.
Publicado: (2014)

miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s disease
por: dos Santos, Marcia Cristina T., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o2a6929b0rq9f0c4qc2cdpn13n